The authors connected IL15 and IL21 to hu14.18, resulting in improved antibody-dependent cell-mediated killing in immune-competent NB models compared to hu14.18-IL2 (Nguyen et al., 2022). The gene discussed is IL2; the disease is neuroblastoma.